Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LSD1-IN-7 Methylbenzenesulfonate is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | LSD1-IN-7 Methylbenzenesulfonate is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity. |
Targets&IC50 | LSD1:0.25 nM (IC50) |
In vivo | LSD1-IN-7 in combination with other LSD1 inhibitor can be treatment of cancer in a mammal, including breast cancer, lioblastoma, leukemia, prostate cancer,or lung cancerg[1]. |
Synonyms | LSD1-IN-7 Methylbenzenesulfonate |
Molecular Weight | 623.67 |
Formula | C31H31F2N5O5S |
CAS No. | 2097523-57-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pulrodemstat Methylbenzenesulfonate 2097523-57-2 Others LSD1-IN-7 Methylbenzenesulfonate inhibitor inhibit